Author
Listed:
- Stefan G. Tullius
(Brigham and Women’s Hospital, Harvard Medical School)
- Hector Rodriguez Cetina Biefer
(Brigham and Women’s Hospital, Harvard Medical School
Clinic for Cardiovascular Surgery, University Hospital Zurich)
- Suyan Li
(Angiogenesis and Brain Development Laboratory, McLean Hospital/Harvard Medical School)
- Alexander J. Trachtenberg
(Harvard Catalyst-Laboratory for Innovative Translational Technologies, Harvard Medical School)
- Karoline Edtinger
(Brigham and Women’s Hospital, Harvard Medical School)
- Markus Quante
(Brigham and Women’s Hospital, Harvard Medical School)
- Felix Krenzien
(Brigham and Women’s Hospital, Harvard Medical School)
- Hirofumi Uehara
(Brigham and Women’s Hospital, Harvard Medical School)
- Xiaoyong Yang
(Brigham and Women’s Hospital, Harvard Medical School)
- Haydn T. Kissick
(Beth Israel Deaconess Medical Center, Harvard Medical School)
- Winston P. Kuo
(Harvard Catalyst-Laboratory for Innovative Translational Technologies, Harvard Medical School)
- Ionita Ghiran
(Beth Israel Deaconess Medical Center, Harvard Medical School)
- Miguel A. de la Fuente
(Instituto de Biología y Genética Molecular, University of Valladolid)
- Mohamed S. Arredouani
(Beth Israel Deaconess Medical Center, Harvard Medical School)
- Virginia Camacho
(Flow Cytometry Core Facility, Beth Israel Deaconess Medical Center, Harvard Stem Cell Institute)
- John C. Tigges
(Flow Cytometry Core Facility, Beth Israel Deaconess Medical Center, Harvard Stem Cell Institute)
- Vasilis Toxavidis
(Flow Cytometry Core Facility, Beth Israel Deaconess Medical Center, Harvard Stem Cell Institute)
- Rachid El Fatimy
(Center for Neurological Diseases, Brigham and Women’s Hospital, Harvard Medical School)
- Brian D. Smith
(Transplantation Research Center, Brigham and Women's Hospital and Children's Hospital, Harvard Medical School)
- Anju Vasudevan
(Angiogenesis and Brain Development Laboratory, McLean Hospital/Harvard Medical School)
- Abdallah ElKhal
(Brigham and Women’s Hospital, Harvard Medical School)
Abstract
CD4+ T cells are involved in the development of autoimmunity, including multiple sclerosis (MS). Here we show that nicotinamide adenine dinucleotide (NAD+) blocks experimental autoimmune encephalomyelitis (EAE), a mouse model of MS, by inducing immune homeostasis through CD4+IFNγ+IL-10+ T cells and reverses disease progression by restoring tissue integrity via remyelination and neuroregeneration. We show that NAD+ regulates CD4+ T-cell differentiation through tryptophan hydroxylase-1 (Tph1), independently of well-established transcription factors. In the presence of NAD+, the frequency of T-bet−/− CD4+IFNγ+ T cells was twofold higher than wild-type CD4+ T cells cultured in conventional T helper 1 polarizing conditions. Our findings unravel a new pathway orchestrating CD4+ T-cell differentiation and demonstrate that NAD+ may serve as a powerful therapeutic agent for the treatment of autoimmune and other diseases.
Suggested Citation
Stefan G. Tullius & Hector Rodriguez Cetina Biefer & Suyan Li & Alexander J. Trachtenberg & Karoline Edtinger & Markus Quante & Felix Krenzien & Hirofumi Uehara & Xiaoyong Yang & Haydn T. Kissick & Wi, 2014.
"NAD+ protects against EAE by regulating CD4+ T-cell differentiation,"
Nature Communications, Nature, vol. 5(1), pages 1-17, December.
Handle:
RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms6101
DOI: 10.1038/ncomms6101
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Xiao-Ru Ma & Xudong Zhu & Yujie Xiao & Hui-Min Gu & Shuang-Shuang Zheng & Liang Li & Fan Wang & Zhao-Jun Dong & Di-Xian Wang & Yang Wu & Chenyu Yang & Wenhong Jiang & Ke Yao & Yue Yin & Yang Zhang & C, 2022.
"Restoring nuclear entry of Sirtuin 2 in oligodendrocyte progenitor cells promotes remyelination during ageing,"
Nature Communications, Nature, vol. 13(1), pages 1-19, December.
- Quetzalcoatl Escalante-Covarrubias & Lucía Mendoza-Viveros & Mirna González-Suárez & Román Sitten-Olea & Laura A. Velázquez-Villegas & Fernando Becerril-Pérez & Ignacio Pacheco-Bernal & Erick Carreño-, 2023.
"Time-of-day defines NAD+ efficacy to treat diet-induced metabolic disease by synchronizing the hepatic clock in mice,"
Nature Communications, Nature, vol. 14(1), pages 1-24, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms6101. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.